Latest Stories
3 Reasons VSH is Risky and 1 Stock to Buy Instead
Vishay Intertechnology currently trades at $15.15 per share and has shown little upside over the past six months, posting a small loss of 3.7%. The stock also fell short of the S&P 500’s 13.1% gain during that period.
LiveRamp (RAMP): Buy, Sell, or Hold Post Q3 Earnings?
Over the last six months, LiveRamp’s shares have sunk to $29.22, producing a disappointing 7.9% loss - a stark contrast to the S&P 500’s 13.1% gain. This may have investors wondering how to approach the situation.
3 Reasons to Sell DOLE and 1 Stock to Buy Instead
Dole trades at $15.60 and has moved in lockstep with the market. Its shares have returned 11.4% over the last six months while the S&P 500 has gained 13.1%.
3 Reasons to Avoid ESNT and 1 Stock to Buy Instead
Essent Group trades at $65.25 and has moved in lockstep with the market. Its shares have returned 10.5% over the last six months while the S&P 500 has gained 13.1%.
Molina Healthcare (MOH): Buy, Sell, or Hold Post Q3 Earnings?
What a brutal six months it’s been for Molina Healthcare. The stock has dropped 42.1% and now trades at $168.08, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell ICUI and 1 Stock to Buy Instead
ICU Medical trades at $148.44 per share and has stayed right on track with the overall market, gaining 11.4% over the last six months. At the same time, the S&P 500 has returned 13.1%.
3 Reasons We Love Shopify (SHOP)
What a fantastic six months it’s been for Shopify. Shares of the company have skyrocketed 46.7%, hitting $158.98. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons DLTR is Risky and 1 Stock to Buy Instead
Dollar Tree’s 32.6% return over the past six months has outpaced the S&P 500 by 19.5%, and its stock price has climbed to $131.25 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons UDMY is Risky and 1 Stock to Buy Instead
Udemy’s stock price has taken a beating over the past six months, shedding 24.7% of its value and falling to $5.30 per share. This might have investors contemplating their next move.
Newmark (NMRK): Buy, Sell, or Hold Post Q3 Earnings?
What a time it’s been for Newmark. In the past six months alone, the company’s stock price has increased by a massive 47.7%, reaching $17.06 per share. This run-up might have investors contemplating their next move.